Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.7200 (-7.29%) ($5.7200 - $5.7200) on Mon. Feb. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.07% (three month average) | RSI | 31 | Latest Price | $5.7200(-7.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -4.6% a day on average for past five trading days. | Weekly Trend | CEMI declines -6.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) XLC(-38%) VXX(-12%) UNG(-17%) SIL(-12%) SKYY(-47%) | Factors Impacting CEMI price | CEMI will decline at least -2.535% in a week (0% probabilities). XRT(-21%) IDRV(-27%) INDA(-88%) IBB(-36%) IWC(-28%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.535% (StdDev 5.07%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $7 | 5 Day Moving Average | $6.46(-11.46%) | 10 Day Moving Average | $6.99(-18.17%) | 20 Day Moving Average | $7(-18.29%) | To recent high | -27.9% | To recent low | 13.6% | Market Cap | $115m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |